RAMSAY DAVID A

Average Profitability
32.27%
Insider Buys Quantity
58
Insider Buys Sum
$3.33M
Insider Sells Quantity
3
Insider Sells Sum
$504,820.09

Insider Activity of RAMSAY DAVID A

The largest purchase of all time was on 2021-03-15 and amounted to 689655 shares of Savara Inc. for $1,000,000.

The largest sale of all time was on 2007-05-14 and amounted to 20000 shares of Halozyme Therapeutics, Inc. for $203,800.

Biography of RAMSAY DAVID A

No biography is available at this moment.

2023-05-26PurchaseSavara Inc.
SVRA
director
37,124
0.024%
$2.63$97,599+44.36%
2023-05-25PurchaseSavara Inc.
SVRA
director
12,876
0.0084%
$2.57$33,130+48.84%
2023-05-24PurchaseSavara Inc.
SVRA
director
50,000
0.0322%
$2.56$127,800+47.69%
2022-12-30PurchaseSavara Inc.
SVRA
director
29,000
0.0189%
$1.55$44,834+101.94%
2022-12-29PurchaseSavara Inc.
SVRA
director
7,000
0.0046%
$1.54$10,752+104.58%
2022-12-28PurchaseSavara Inc.
SVRA
director
3,293
0.0021%
$1.50$4,923+107.67%
2022-12-23PurchaseSavara Inc.
SVRA
director
15,707
0.0099%
$1.44$22,665+105.33%
2022-12-22PurchaseSavara Inc.
SVRA
director
41,414
0.0274%
$1.48$61,127+110.62%
2022-12-20PurchaseSavara Inc.
SVRA
director
13,830
0.0092%
$1.50$20,759+104.73%
2022-12-20PurchaseSavara Inc.
SVRA
director
3,586
0.0023%
$1.48$5,307+104.73%
2022-12-20PurchaseSavara Inc.
SVRA
director
17,416
0.0115%
$1.50$26,066+104.73%
2022-12-19PurchaseSavara Inc.
SVRA
director
40,719
0.0271%
$1.49$60,834+104.42%
2022-12-16PurchaseSavara Inc.
SVRA
director
341
0.0002%
$1.50$512+95.39%
2022-11-23PurchaseSavara Inc.
SVRA
director
4,610
0.003%
$1.44$6,634+84.83%
2022-11-22PurchaseSavara Inc.
SVRA
director
15,495
0.0101%
$1.42$22,018+88.38%
2022-11-21PurchaseSavara Inc.
SVRA
director
25,005
0.0163%
$1.42$35,532+86.36%
2022-11-18PurchaseSavara Inc.
SVRA
director
16,100
0.0103%
$1.34$21,606+94.16%
2022-11-17PurchaseSavara Inc.
SVRA
director
8,900
0.0056%
$1.27$11,303+102.67%
2022-09-06PurchaseSavara Inc.
SVRA
870
0.0006%
$1.38$1,201+43.53%
2022-08-30PurchaseSavara Inc.
SVRA
20,738
0.0137%
$1.41$29,261+39.64%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.